Microscopic Colitis: Understanding Chronic Diarrhea and Why Budesonide Is the Gold Standard Treatment

Chronic diarrhea that won’t go away-no blood, no fever, no obvious cause-can be one of the most frustrating health mysteries. For thousands of people, especially women over 60, this isn’t just an inconvenience. It’s a life disrupted: skipping social events, avoiding travel, waking up at 3 a.m. to rush to the bathroom. The culprit? Microscopic colitis.

Unlike Crohn’s or ulcerative colitis, where inflammation is visible during a colonoscopy, microscopic colitis hides in plain sight. Your colon looks perfectly normal to the naked eye. But under the microscope, something’s wrong. Either there’s a thickened collagen band under the lining (collagenous colitis) or a flood of white blood cells between the cells (lymphocytic colitis). Both cause the colon to lose its ability to absorb water. The result? Five to ten watery bowel movements a day, often for months or even years before anyone figures it out.

What Makes Microscopic Colitis Different

Most people assume chronic diarrhea means infection, food intolerance, or IBS. But if you’ve had watery diarrhea for more than three weeks-with no blood, no weight loss at first, and no response to probiotics or dietary changes-it’s time to consider microscopic colitis. It’s not rare. Studies show about 5 out of every 100,000 people get it each year, and that number is rising as doctors get better at testing for it.

Women make up nearly 70% of cases. The average age at diagnosis? Early 60s. Many patients have other conditions too-thyroid disease, arthritis, or celiac disease. Medications play a role: NSAIDs like ibuprofen, proton pump inhibitors like omeprazole, and even certain antidepressants can trigger it in susceptible people. But not everyone who takes these drugs gets it. There’s a genetic and immune component we’re still learning about.

Diagnosis requires a biopsy. Not just one, but multiple samples from different parts of the colon during a colonoscopy. Why? Because the inflammation isn’t spread evenly. A single biopsy might miss it. That’s why it takes, on average, 11 months from the first symptom to get a correct diagnosis. Many patients see three or four doctors before someone thinks to take tissue samples.

Why Budesonide Works So Well

Before budesonide, the go-to treatment was prednisone-a powerful steroid that works but comes with a heavy cost. Weight gain, mood swings, high blood sugar, bone thinning. For older adults, the risks often outweighed the benefits.

Budesonide changed everything. It’s still a steroid, but it’s designed to act locally in the gut and get broken down quickly by the liver. Only 10-15% of the drug enters your bloodstream. That’s why side effects are so much milder. In clinical trials, 84% of patients with collagenous colitis went into complete remission after eight weeks of 9mg daily budesonide. Compare that to just 38% on placebo. The same numbers hold for lymphocytic colitis.

Most people notice improvement within two weeks. One patient on PatientsLikeMe wrote: “Went from 10 bathroom trips a day to 2 in 10 days. I cried when I realized I could leave the house without a plan.” That’s not an outlier. Multiple studies confirm 70-85% of patients achieve remission within 4 to 8 weeks.

The Catch: Relapse Is Common

Here’s the hard truth: budesonide doesn’t cure microscopic colitis. It controls it. Once you stop taking it, about half of patients relapse within six months. That’s why maintenance therapy is often needed.

For those who keep having symptoms after the initial 6-8 week course, doctors typically switch to a lower daily dose-6mg instead of 9mg-and keep it going for months, sometimes years. This isn’t ideal. Long-term steroid use, even low-dose, can still affect bone density and adrenal function, especially in older adults. That’s why doctors monitor bone scans and blood sugar regularly.

Some patients get stuck on budesonide for two or three years. One Reddit user shared: “I’m on maintenance now. I can’t stop. If I do, I’m back to 10 trips a day. It’s like I’m addicted to a steroid.”

What Else Works? (And What Doesn’t)

Budesonide is the gold standard, but it’s not the only option. And not everyone tolerates it.

• Bismuth subsalicylate (Pepto-Bismol): Works for about 26% of people. Cheap, accessible, but not strong enough for severe cases.
• Mesalamine: Used for ulcerative colitis, helps about 40-50% of microscopic colitis patients. Often tried if budesonide isn’t an option.
• Cholestyramine: Binds bile acids. If your diarrhea is caused by excess bile (common in MC), this can cut symptoms by 60-70%. Often used in combination with budesonide.
• Prednisone: Works as well as budesonide-but with 3 times the side effects. Only used if budesonide fails or isn’t available.
• Anti-TNF drugs (like infliximab): Too expensive, too risky. Reserved for rare cases that don’t respond to anything else.

Combination therapy is becoming more common. One patient told me: “Budesonide fixed my inflammation, but cholestyramine stopped the leftover diarrhea. Together, they gave me my life back.”

Cost and Access

Generic budesonide capsules cost $150-$250 for an 8-week course. The brand version, Entocort EC, can run $800-$1,200. That’s a huge difference if you’re uninsured or on a fixed income. Since the FDA approved generics in 2018, access has improved-but not everywhere. In rural areas or countries without robust healthcare systems, budesonide is still hard to get.

Insurance coverage varies. Some plans require step therapy-trying cheaper options first-even though evidence shows budesonide is the most effective starting point. Patients often spend months fighting for approval.

What’s Next? The Future of Treatment

Researchers are working on better options. A new drug called vedolizumab, which targets gut-specific inflammation, showed 65% remission in early trials. It’s not approved yet, but it’s in fast-track review by the FDA. That could mean a steroid-free future for some patients.

Genetics might also play a role. Early data suggests people with certain immune genes (HLA-DQ2/DQ8) respond better to budesonide. In the next five years, we may see tests to predict who will benefit most from this drug-cutting out trial and error.

For now, budesonide remains the most reliable tool we have. The European Microscopic Colitis Group gives it the highest recommendation (GRADE 1A) based on solid evidence. In Scandinavia, where microscopic colitis is most common, nearly 92% of doctors start with it. In the U.S. and Europe, it’s 85%.

What Patients Should Know

If you’re diagnosed:

• Start budesonide 9mg daily for 6-8 weeks. Don’t skip doses.
• Expect improvement in 10-14 days. If nothing changes by week 4, talk to your doctor.
• Ask about bone density testing if you’re over 50.
• Don’t stop abruptly. Taper slowly-reduce by 3mg every 2-4 weeks-to lower relapse risk.
• Keep a symptom diary. Note frequency, urgency, and any triggers (like caffeine, dairy, or NSAIDs).
• Consider adding cholestyramine if diarrhea lingers after budesonide.

If you’re still suffering after treatment, don’t give up. Microscopic colitis is manageable. It’s not life-threatening. But it can steal years of quality life if left untreated or misdiagnosed.

Microscopic colitis isn’t a death sentence. It’s not even a rare disease anymore. But it’s still underdiagnosed, and many patients suffer for years before getting the right treatment. Budesonide isn’t perfect-but it’s the best we have right now. For the vast majority, it means going from constant bathroom runs to living without fear. And that’s worth more than any pill price tag.